Treatment | Gene Transcription Rate (Percentage of Control) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
CYP2C11 | CYP3A2 | CYP2E1 | CYP4A1 | Haptoglobin | Angiotensinogen | ||||||
Control (1 h) | 100 ± 10 | 100 ± 9 | 100 ± 45 | 100 ± 10 | 100 ± 16 | 100 ± 74 | |||||
LPS (1 h) | 17 ± 4a | 29 ± 6a | 10 ± 6 | 461 ± 49a | 375 ± 62a | 627 ± 213a | |||||
Control (2 h) | 100 ± 18 | 100 ± 21 | 100 ± 29 | 100 ± 17 | 100 ± 12 | 100 ± 32 | |||||
Curcumin (2 h) | 106 ± 12 | 107 ± 14 | 95 ± 7 | 65 ± 12 | 117 ± 13a | 96 ± 25 | |||||
LPS (2 h) | 21 ± 3a | 30 ± 8a | 12 ± 3a | 72 ± 12 | 196 ± 17 | 842 ± 217a | |||||
LPS + curcumin (2 h) | 36 ± 10a | 108 ± 23b | 50 ± 12b | 139 ± 25b | 200 ± 14a | 1011 ± 250a |